Bach Pharma

Bach Pharma, Inc. (Bach) is a privately held pharmaceutical company at the forefront of developing revolutionary therapies based on phthalazinone dione for the treatment of life-threatening diseases. The programs led by Bach target degenerative neurological disorders with the aim of significantly improving patients' lives and reducing global healthcare costs.